📰 Administered News
Page 14 - Administered News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Administered. Real-time updates on events, politics, business and more.
December 21, 2021
With the administration of over 51 lakh COVID-19 vaccine doses till 7 pm on Tuesday, Indias cumulative vaccination coverage exceeded 138.89 crore doses, informed the Ministry of Health and Family Welfare.
December 18, 2021
Advice to strictly follow health guidelines during the festive season Hiru News Most visited website in Sri Lanka,Sri Lanka Latest news updates from Sri Lanka. Sri Lanka News updates and discussions. Welcome to the No1 online news Site for Sri Lankans. A Rayynor Silva Holdings Company
December 16, 2021
Initial results show excellent immune response after third dose of VLA2001 administered 7 to 8 months after the second dose of primary vaccinationAntibody titers increased 42- to 106-fold two... | December 16, 2021
December 16, 2021
NEW BRITAIN - It has been one year since the first covid-19 vaccine was administered to Hartford H...
December 16, 2021
Amid the spread of new COVID-19 variant Omicron, World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus on Thursday raised concern over the low vaccin
December 16, 2021
Amid the spread of new COVID-19 variant Omicron, World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus on Thursday raised concern over the low vaccin
December 11, 2021
Cellectis’ Proprietary Product Candidate UCART22 was Administered after Lymphodepletion with Fludarabine, Cyclophosphamide and Alemtuzumab with no Dose-Limiting Toxicities in BALLI-01... | December 11, 2021
December 9, 2021
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) will hold the first meeting on Friday regarding the COVID-19 bo
December 9, 2021
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) will hold the first meeting on Friday regarding the COVID-19 bo
December 6, 2021
First and only neutralizing antibody therapy for this age groupSHANGHAI, China, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical